These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 17114044)

  • 41. Novel LRRK2 mutations in Parkinsonism.
    Trinh J; Guella I; McKenzie M; Gustavsson EK; Szu-Tu C; Petersen MS; Rajput A; Rajput AH; McKeown M; Jeon BS; Aasly JO; Bardien S; Farrer MJ
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1119-21. PubMed ID: 26213354
    [No Abstract]   [Full Text] [Related]  

  • 42. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.
    Skibinski G; Nakamura K; Cookson MR; Finkbeiner S
    J Neurosci; 2014 Jan; 34(2):418-33. PubMed ID: 24403142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.
    Puccini JM; Marker DF; Fitzgerald T; Barbieri J; Kim CS; Miller-Rhodes P; Lu SM; Dewhurst S; Gelbard HA
    J Neurosci; 2015 Apr; 35(13):5271-83. PubMed ID: 25834052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autosomal recessive juvenile parkinsonism: a key to understanding nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Kitada T; Wang M; Asakawa S; Minashima S; Shimizu N; Suzuki T; Tanaka K; Mizuno Y
    Neuropathology; 2000 Sep; 20 Suppl():S85-90. PubMed ID: 11037196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
    Klein C; Lohmann-Hedrich K; Rogaeva E; Schlossmacher MG; Lang AE
    Lancet Neurol; 2007 Jul; 6(7):652-62. PubMed ID: 17582365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leucine-rich repeat kinase 2 associates with lipid rafts.
    Hatano T; Kubo S; Imai S; Maeda M; Ishikawa K; Mizuno Y; Hattori N
    Hum Mol Genet; 2007 Mar; 16(6):678-90. PubMed ID: 17341485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.
    González-Fernández MC; Lezcano E; Ross OA; Gómez-Esteban JC; Gómez-Busto F; Velasco F; Alvarez-Alvarez M; Rodríguez-Martínez MB; Ciordia R; Zarranz JJ; Farrer MJ; Mata IF; de Pancorbo MM
    Parkinsonism Relat Disord; 2007 Dec; 13(8):509-15. PubMed ID: 17540608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
    Schüpbach M; Lohmann E; Anheim M; Lesage S; Czernecki V; Yaici S; Worbe Y; Charles P; Welter ML; Pollak P; Dürr A; Agid Y; Brice A
    Mov Disord; 2007 Jan; 22(1):119-22. PubMed ID: 17080443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apoptotic mechanisms in mutant LRRK2-mediated cell death.
    Iaccarino C; Crosio C; Vitale C; Sanna G; Carrì MT; Barone P
    Hum Mol Genet; 2007 Jun; 16(11):1319-26. PubMed ID: 17409193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth.
    Kawakami F; Yabata T; Ohta E; Maekawa T; Shimada N; Suzuki M; Maruyama H; Ichikawa T; Obata F
    PLoS One; 2012; 7(1):e30834. PubMed ID: 22303461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
    Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
    Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß.
    Lin CH; Tsai PI; Wu RM; Chien CT
    J Neurosci; 2010 Sep; 30(39):13138-49. PubMed ID: 20881132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect.
    Sheng D; Qu D; Kwok KH; Ng SS; Lim AY; Aw SS; Lee CW; Sung WK; Tan EK; Lufkin T; Jesuthasan S; Sinnakaruppan M; Liu J
    PLoS Genet; 2010 Apr; 6(4):e1000914. PubMed ID: 20421934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease.
    Hedrich K; Winkler S; Hagenah J; Kabakci K; Kasten M; Schwinger E; Volkmann J; Pramstaller PP; Kostic V; Vieregge P; Klein C
    Mov Disord; 2006 Sep; 21(9):1506-10. PubMed ID: 16758483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions.
    Dächsel JC; Ross OA; Mata IF; Kachergus J; Toft M; Cannon A; Baker M; Adamson J; Hutton M; Dickson DW; Farrer MJ
    Acta Neuropathol; 2007 May; 113(5):601-6. PubMed ID: 17151837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease.
    Melrose HL; Kent CB; Taylor JP; Dachsel JC; Hinkle KM; Lincoln SJ; Mok SS; Culvenor JG; Masters CL; Tyndall GM; Bass DI; Ahmed Z; Andorfer CA; Ross OA; Wszolek ZK; Delldonne A; Dickson DW; Farrer MJ
    Neuroscience; 2007 Jul; 147(4):1047-58. PubMed ID: 17611037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. alpha-synuclein and LRRK2: partners in crime.
    Tong Y; Shen J
    Neuron; 2009 Dec; 64(6):771-3. PubMed ID: 20064381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in LRRK2 as a cause of Parkinson's disease.
    Giasson BI; Van Deerlin VM
    Neurosignals; 2008; 16(1):99-105. PubMed ID: 18097165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.